Denis F. Jardim

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Urinary microbiota diversity and composition in patients with advanced renal cell cancer.

Urinary microbiota diversity and composition in patients with advanced renal cell cancer.

Journal: BJUI compass
Published: January 04, 2026

Latin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer.

Latin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer.

Journal: Clinical genitourinary cancer
Published: November 26, 2025

Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.

Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.

Journal: Pathology, research and practice
Published: November 14, 2024

Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitors.

Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitors.

Journal: The oncologist
Published: October 31, 2024

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Journal: Journal of cancer research and clinical oncology
Published: December 27, 2023

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Journal: Clinical genitourinary cancer
Published: November 19, 2023

Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.

Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.

Journal: The Prostate
Published: September 14, 2023

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.

Journal: International journal of molecular sciences
Published: August 30, 2023

The bladder microbiota is not significantly altered by intravesical BCG therapy.

The bladder microbiota is not significantly altered by intravesical BCG therapy.

Journal: Urologic oncology
Published: June 13, 2023

PD-L1 gene amplification and focality: relationship with protein expression.

PD-L1 gene amplification and focality: relationship with protein expression.

Journal: Journal for immunotherapy of cancer
Published: February 14, 2023

Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.

Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.

Journal: JCO precision oncology
Published: January 09, 2023

Low-energy amplitude-modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.

Low-energy amplitude-modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.

Journal: Cancer medicine
Published: November 29, 2022
Showing 1-12 of 64

Last Updated: 09/26/2026